Matt, Author at European Medical Journal - Page 41 of 212

EMJ Hepatology [Supplement 2] ILC Congress Review 2020

Precision Medicine in NAFLD: Are We There Yet?

PRESENTING at an interactive session entitled ‘Precision medicine for the management of NAFLD – Are we there yet?’ at The Digital…

EMJ Hepatology [Supplement 2] ILC Congress Review 2020

FIB-4 and APRI Scores Revalidation in a Cohort Study of 69,106 Chronic Hepatitis C Patients

Assessment of liver fibrosis is vital for enabling therapeutic decisions and prognostic evaluation of chronic hepatitis…

EMJ Hepatology [Supplement 2] ILC Congress Review 2020

Progress in Hepatitis C Testing as Part of the Hepatitis C Elimination Programme in Georgia

In April 2015, the country of Georgia, with a high prevalence of hepatitis C virus (HCV) infection (5.4% of the adult population, approximately 150,000 persons), embarked on the world’s first national HCV Elimination programme…

ILC Congress Interview: Prof Christian Trautwein

Prof Christian Trautwein | European Association for the Study of the Liver (EASL) Ethics Committee ChairpersonThe Department of Gastroenterology…

EMJ Hepatology [Supplement 2] ILC Congress Review 2020

Multivariant Surface Quasispecies in a Hepatitis B Virus Chronically Infected Individual with Concomitant and Continually Positive Surface Antigen and Anti-Hbs Biomarkers

Coexistence of hepatitis B virus (HBV) surface antigen (HBsAg) and antibodies (anti-HBs) can be found in 2.3–5.2% of chronic HBV (CHB) infected individuals…

EMJ Hepatology [Supplement 2] ILC Congress Review 2020

Contrast-Enhanced Ultrasound Algorithms for the Noninvasive Diagnosis of Hepatocellular Carcinoma in High-Risk Patients - A Prospective Multicentre Study (DEGUM CEUS HCC Trial)

Hepatocellular carcinoma (HCC) can be diagnosed noninvasively in high-risk patients by means of contrast-enhanced imaging…

Cardiology CP

High-Density Lipoproteins and Cardiovascular Disease

For >20 years, clinical trials have consistently demonstrated that the reduction of levels of low-density lipoprotein (LDL) cholesterol results in lower cardiovascular event rates, in both the primary and secondary prevention setting…

Continuing Challenges in the Medical Management of Gestational Diabetes Mellitus

Gestational diabetes mellitus (GDM) is hyperglycaemia first detected in pregnancy, short of overt diabetes in pregnancy (DIP)…

Genomic Profiling and the Future of Early Breast Cancer Care

Hear from the experts in the field of early-stage breast cancer on the performance and utility of the Prosigna® breast cancer prognostic gene signature in this webinar.

Transcutaneous carbon dioxide monitoring

The Sentec ERS Symposia on the topic of Advances in transcutaneous CO2 monitoring in the acute and chronic setting: from science to clinical application…